Intervention Review

Chemotherapy for hormone-refractory prostate cancer

  1. Mike Shelley1,*,
  2. Craig Harrison2,
  3. Bernadette Coles3,
  4. John Stafforth4,
  5. Timothy Wilt5,
  6. Malcolm Mason6

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 18 OCT 2006

Assessed as up-to-date: 9 JUL 2006

DOI: 10.1002/14651858.CD005247.pub2

How to Cite

Shelley M, Harrison C, Coles B, Stafforth J, Wilt T, Mason M. Chemotherapy for hormone-refractory prostate cancer. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD005247. DOI: 10.1002/14651858.CD005247.pub2.

Author Information

  1. 1

    Velindre NHS Trust, Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept, Cardiff, Wales, UK

  2. 2

    Velindre NHS Trust, Cardiff, Wales, UK

  3. 3

    Cardiff University , Cancer Research Wales Library, Cardiff, UK

  4. 4

    Velindre NHS Trust, Research Department, Cardiff, Wales, UK

  5. 5

    VAMC, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

  6. 6

    Velindre Hospital, Clinical Oncology, Cardiff, UK

*Mike Shelley, Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept, Velindre NHS Trust, Velindre Road, Whitchurch, Cardiff, Wales, CF4 7XL, UK. mike.shelley@velindre-tr.wales.nhs.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2006

SEARCH

  1. Current Version

    Chemotherapy for hormone-refractory prostate cancer

    Mike Shelley, Craig Harrison, Bernadette Coles, John Stafforth, Timothy Wilt and Malcolm Mason

    Article first published online: 18 OCT 2006 | DOI: 10.1002/14651858.CD005247.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Chemotherapy for advanced prostate cancer

    M Shelley, C Harrison, B Coles, T Wilt and M Mason

    Article first published online: 24 JAN 2005 | DOI: 10.1002/14651858.CD005247